China

News

Innovent files high-dose mazdutide for obesity in China

Innovent has filed a new high-strength version of its weight-loss drug mazdutide in China, aiming to help people with severe obesity.

R&D

Global pharmaceutical market projections through 2030

Global pharmaceutical market projections through 2030, with Norstella's Daniel Chancellor.

News

US vulnerable to China's API dominance, says report

China has such a dominant position in pharmaceutical ingredient production that there is a risk it will weaponise access, says a Congressional report.

News

Kelun gets world-first approval for TROP2 ADC

Kelun-Biotech has picked up another world-first approval for its TROP2-targeting ADC sac-TMT in non-small cell lung cancer.

News

Sanofi grabs Chinese rights to Arrowhead rare disease drug

Sanofi has paid $130 million upfront for Chinese rights to an Arrowhead Pharma drug for rare disease familial chylomicronaemia syndrome.

News

Bayer files HER2+ lung cancer drug in China

Bayer files its oral HER2+ lung cancer drug in China, as it extends a race to market with rival Boehringer Ingelheim.

Innovent files high-dose mazdutide for obesity in China

Global pharmaceutical market projections through 2030

US vulnerable to China's API dominance, says report

Kelun gets world-first approval for TROP2 ADC

Sanofi grabs Chinese rights to Arrowhead rare disease drug

Bayer files HER2+ lung cancer drug in China

As Ebola deaths climb, search begins for vaccine

Discover a new era of healthcare panel engagement: Grounded ...

China

Editor's Picks